Technical Analysis for TAIPY - Taisho Pharmaceutical Holdings ADR

Grade Last Price % Change Price Change
grade D 14.49 -1.36% -0.2000
TAIPY closed down 1.36 percent on Wednesday, July 8, 2020, on 56 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical TAIPY trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Gapped Down Weakness 0.00%
180 Bearish Setup Bearish Swing Setup -1.36%
Narrow Range Bar Range Contraction -1.36%
NR7 Range Contraction -1.36%
Inside Day Range Contraction -1.36%
Narrow Range Bar Range Contraction -2.82%
Gapped Up Strength -2.82%
Narrow Range Bar Range Contraction 3.35%
Down 3 Days in a Row Weakness 3.35%
Older signals for TAIPY ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Taisho Pharmaceutical Holdings Co., Ltd., through its subsidiaries, researches, develops, manufactures, and sells over-the-counter (OTC) drugs and prescription pharmaceuticals in Japan and internationally. It operates in two segments, Self-Medication Operation Group and Prescription Pharmaceutical Operation Group. The Self-Medication Operation Group segment offers OTC drugs, quasi-drugs, food products, and general medical and hygiene supplies, such as Lipovitan series of energy drinks; the Pabron series of cold remedies and sinus treatments, as well as gargles, hand-washing treatments, and face masks; the RiUP series of hair re-growth treatment products; the Taisho Kampo Ichoyaku series of gastrointestinal treatment products; the Colac series of laxative products; and Livita series of food products for specialized health use, as well as engages in the real estate leasing and facility management, and hotel management operations. The Prescription Pharmaceutical Operation Group segment offers ethical drugs, including ZOSYN, an injectable antibiotic; Edirol, an active vitamin D3 osteoporosis agent; Clarith, a macrolide antibiotic; Palux, a peripheral vasodilator; OZEX and Geninax, quinolone antibacterial; Bonviva, a bisphosphonate antiresorptive agent; Biofermin, a live lactobacillus preparation; Lusefi, a type 2 diabetes mellitus agent; and LOQOA, a transdermal anti-inflammatory analgesic. This segment has various products under development primarily in therapeutic areas, such as central nervous system, infectious, and metabolic diseases, as well as orthopedic disorders. The company also offers raw materials for pharmaceuticals and quasi-drugs; and supplies health foods and skin care products. Taisho Pharmaceutical Holdings Co., Ltd. was founded in 1912 and is headquartered in Tokyo, Japan.
Health Pharmaceutical Industry Pharmaceuticals Drugs Pharmacy Food Products Pharmaceutical Industry In China Diabetes Medication Pharmaceuticals Policy Skin Care Products Energy Drinks Metabolic Diseases Medical Prescription Clinical Pharmacology Facility Management Real Estate Leasing Prescription Drug Over The Counter Drug Prescription Pharmaceuticals

Is TAIPY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 19.53
52 Week Low 12.11
Average Volume 6,581
200-Day Moving Average 16.5785
50-Day Moving Average 15.0765
20-Day Moving Average 15.0047
10-Day Moving Average 14.7735
Average True Range 1.0411
ADX 25.71
+DI 15.7651
-DI 23.5016
Chandelier Exit (Long, 3 ATRs ) 13.5767
Chandelier Exit (Short, 3 ATRs ) 16.5233
Upper Bollinger Band 16.1208
Lower Bollinger Band 13.8886
Percent B (%b) 0.27
BandWidth 14.8767
MACD Line -0.1461
MACD Signal Line -0.0755
MACD Histogram -0.0706
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.7300
Resistance 3 (R3) 14.7133 14.6167 14.6900
Resistance 2 (R2) 14.6167 14.5555 14.6250 14.6767
Resistance 1 (R1) 14.5533 14.5178 14.5850 14.5700 14.6633
Pivot Point 14.4567 14.4567 14.4725 14.4650 14.4567
Support 1 (S1) 14.3933 14.3955 14.4250 14.4100 14.3167
Support 2 (S2) 14.2967 14.3578 14.3050 14.3033
Support 3 (S3) 14.2333 14.2967 14.2900
Support 4 (S4) 14.2500